Idorsia Ltd (IDRSF)
OTCMKTS · Delayed Price · Currency is USD
4.750
-0.250 (-5.00%)
At close: Feb 10, 2026
Idorsia Market Cap
Idorsia has a market cap or net worth of $1.25 billion as of February 12, 2026. Its market cap has increased by 722.28% in one year.
Market Cap
1.25B
Enterprise Value
2.80B
Revenue
291.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.75
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.67B to 1.25B, a decrease of -25.15%. That is a compound annual growth rate of -3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.25B | -6.98% |
| Dec 30, 2025 | 1.34B | 687.59% |
| Dec 30, 2024 | 170.68M | -61.86% |
| Dec 29, 2023 | 447.53M | -82.63% |
| Dec 30, 2022 | 2.58B | -28.59% |
| Dec 30, 2021 | 3.61B | -24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |